tiprankstipranks
Advertisement
Advertisement

ENTX Stock Latest News

Entera Bio Strengthens Finances to Advance Oral Peptide Pipeline
Company AnnouncementsEntera Bio Strengthens Finances to Advance Oral Peptide Pipeline
9d ago
8K
ENTX
ENTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ENTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
12d ago
ENTX
Why the World’s Leading Healthcare Funds All Wanted a Piece of Entera Bio (NASDAQ: ENTX)
PremiumTipRanks Newswire
Why the World’s Leading Healthcare Funds All Wanted a Piece of Entera Bio (NASDAQ: ENTX)
17d ago
ENTX
Entera Bio Raises $275M in Strategic Private Placement
PremiumCompany Announcements
Entera Bio Raises $275M in Strategic Private Placement
19d ago
8K
ENTX
3 Top Penny Stocks to Watch Today, 7/28/2026
PremiumMarket News
3 Top Penny Stocks to Watch Today, 7/28/2026
19d ago
BIYA
DFNS
Entera Bio announces $275M private placement
PremiumThe FlyEntera Bio announces $275M private placement
20d ago
ENTX
Entera Bio Expands Share Authorization and Equity Plans
Premium
Company Announcements
Entera Bio Expands Share Authorization and Equity Plans
1M ago
8K
ENTX
After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?
Premium
TipRanks Newswire
After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?
1M ago
AZN
LLY
America’s Osteoporosis Crisis and the Oral Peptide Player You Should Watch (NASDAQ: ENTX)
PremiumTipRanks Newswire
America’s Osteoporosis Crisis and the Oral Peptide Player You Should Watch (NASDAQ: ENTX)
1M ago
ENTX
Entera Bio: Buy Rating Reiterated on De-Risked Oral PTH Platform and FDA-Supported Phase 3 Design; $9 Price Target Maintained
PremiumRatings
Entera Bio: Buy Rating Reiterated on De-Risked Oral PTH Platform and FDA-Supported Phase 3 Design; $9 Price Target Maintained
2M ago
ENTX
Entera Bio gets FDA feedback on registrational protocol for EB613
PremiumThe Fly
Entera Bio gets FDA feedback on registrational protocol for EB613
2M ago
ENTX
With Positive FDA Feedback on Phase 3, Entera Bio Just Got the Answer the Market Was Waiting For
PremiumTipRanks Newswire
With Positive FDA Feedback on Phase 3, Entera Bio Just Got the Answer the Market Was Waiting For
2M ago
ENTX
After Novo Nordisk’s Oral Peptide Playbook Made History – Could Entera be The Next Big Peptide Story?
PremiumTipRanks NewswireAfter Novo Nordisk’s Oral Peptide Playbook Made History – Could Entera be The Next Big Peptide Story?
2M ago
NVO
ENTX
Entera Bio and Opko Health present preclinical data for oral peptides
Premium
The Fly
Entera Bio and Opko Health present preclinical data for oral peptides
2M ago
OPK
ENTX
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
Premium
TipRanks Newswire
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
3M ago
NVO
ARWR
Entera Bio Faces Elevated Operational Risks Amid Escalating Middle East Geopolitical Tensions
PremiumCompany Announcements
Entera Bio Faces Elevated Operational Risks Amid Escalating Middle East Geopolitical Tensions
3M ago
ENTX
Entera Bio files to sell 19.57M ordinary shares for holders
PremiumThe Fly
Entera Bio files to sell 19.57M ordinary shares for holders
3M ago
ENTX
Entera Bio Highlights Q1 2026 Progress and Financing
PremiumCompany Announcements
Entera Bio Highlights Q1 2026 Progress and Financing
3M ago
8K
ENTX
Entera Bio price target lowered to $9 from $10 at H.C. Wainwright
PremiumThe Fly
Entera Bio price target lowered to $9 from $10 at H.C. Wainwright
4M ago
ENTX
Entera Bio Announces $10 Million Private Placement Financing
PremiumCompany AnnouncementsEntera Bio Announces $10 Million Private Placement Financing
5M ago
8K
ENTX
Entera Bio Reports 2025 Results, Advances Oral Osteoporosis Pipeline
Premium
Company Announcements
Entera Bio Reports 2025 Results, Advances Oral Osteoporosis Pipeline
5M ago
8K
ENTX
Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market
Premium
TipRanks Newswire
Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market
5M ago
LLY
ENTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >